Patients who are prescribed antibiotics during immune checkpoint blockade therapy for solid tumors face a heightened risk for ...

Treating cancer with immunotherapies known as an immune checkpoint blockade (ICB) prior to surgery (so-called neoadjuvant immunotherapy) has been a rapidly growing area of research, but the scientific ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment. Publishing in Nature Immunology, ...

In a study published in the journal Biofunctional materials, researchers from the Wits Advanced Drug Delivery Platform (WADDP) Research Unit, Department of Pharmacy and Pharmacology, and the Division ...

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors in France. Feasibility of tumor-informed circulating tumor DNA (ctDNA) for molecular ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Scientists at MD Anderson Cancer Center discovered that the mitochondrial enzyme GFER promotes an immunosuppressive tumor environment in pancreatic cancer.